Subscribe To
EDSA / Edesa Biotech: Leader In Developing Treatments For COVID-19 And ACD
EDSA News
By Accesswire
March 16, 2023
Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting
TORONTO, ON / ACCESSWIRE / March 16, 2023 / Edesa Biotech, Inc. announced today that the company has been selected to present clinical trial data from more_horizontal
By Seeking Alpha
April 18, 2022
Edesa Biotech: Leader In Developing Treatments For COVID-19 And ACD
Edesa is one of 4 pharmaceutical companies that received a grant from the Canadian government to develop a drug to treat COVID-19. EB01 achieved all e more_horizontal